351 related articles for article (PubMed ID: 8613352)
1. Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci.
Dale JB; Washburn RG; Marques MB; Wessels MR
Infect Immun; 1996 May; 64(5):1495-501. PubMed ID: 8613352
[TBL] [Abstract][Full Text] [Related]
2. Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A Streptococcus.
Moses AE; Wessels MR; Zalcman K; Albertí S; Natanson-Yaron S; Menes T; Hanski E
Infect Immun; 1997 Jan; 65(1):64-71. PubMed ID: 8975893
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of complement-mediated opsonization and phagocytosis of Streptococcus pyogenes by D fragments of fibrinogen and fibrin bound to cell surface M protein.
Whitnack E; Beachey EH
J Exp Med; 1985 Dec; 162(6):1983-97. PubMed ID: 3906018
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci.
Wessels MR; Moses AE; Goldberg JB; DiCesare TJ
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8317-21. PubMed ID: 1656437
[TBL] [Abstract][Full Text] [Related]
5. Anti-phagocytic mechanisms of Streptococcus pyogenes: binding of fibrinogen to M-related protein.
Courtney HS; Hasty DL; Dale JB
Mol Microbiol; 2006 Feb; 59(3):936-47. PubMed ID: 16420362
[TBL] [Abstract][Full Text] [Related]
6. Effects on virulence of mutations in a locus essential for hyaluronic acid capsule expression in group A streptococci.
Wessels MR; Goldberg JB; Moses AE; DiCesare TJ
Infect Immun; 1994 Feb; 62(2):433-41. PubMed ID: 8300204
[TBL] [Abstract][Full Text] [Related]
7. M proteins of group G streptococci: mechanisms of resistance to phagocytosis.
Campo RE; Schultz DR; Bisno AL
J Infect Dis; 1995 Mar; 171(3):601-6. PubMed ID: 7876607
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin.
Gemmell CG; Peterson PK; Schmeling D; Kim Y; Mathews J; Wannamaker L; Quie PG
J Clin Invest; 1981 May; 67(5):1249-56. PubMed ID: 7014632
[TBL] [Abstract][Full Text] [Related]
9. Restricted deposition of C3 on M+ group A streptococci: correlation with resistance to phagocytosis.
Jacks-Weis J; Kim Y; Cleary PP
J Immunol; 1982 Apr; 128(4):1897-902. PubMed ID: 7037956
[TBL] [Abstract][Full Text] [Related]
10. Variable susceptibility to opsonophagocytosis of group A streptococcus M-1 strains by human immune sera.
Villaseñor-Sierra A; McShan WM; Salmi D; Kaplan EL; Johnson DR; Stevens DL
J Infect Dis; 1999 Dec; 180(6):1921-8. PubMed ID: 10558949
[TBL] [Abstract][Full Text] [Related]
11. Critical role of the group A streptococcal capsule in pharyngeal colonization and infection in mice.
Wessels MR; Bronze MS
Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12238-42. PubMed ID: 7991612
[TBL] [Abstract][Full Text] [Related]
12. M protein expression is not required for resistance to phagocytosis of type 18 group A streptococci.
Liu S; Courtney HS; Bessen DE; Hasty DL; Dale JB
Adv Exp Med Biol; 1997; 418():725-7. PubMed ID: 9331754
[No Abstract] [Full Text] [Related]
13. Acquisition of regulators of complement activation by Streptococcus pyogenes serotype M1.
Pandiripally V; Gregory E; Cue D
Infect Immun; 2002 Nov; 70(11):6206-14. PubMed ID: 12379699
[TBL] [Abstract][Full Text] [Related]
14. Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci.
Marques MB; Kasper DL; Pangburn MK; Wessels MR
Infect Immun; 1992 Oct; 60(10):3986-93. PubMed ID: 1398910
[TBL] [Abstract][Full Text] [Related]
15. Spa contributes to the virulence of type 18 group A streptococci.
McLellan DG; Chiang EY; Courtney HS; Hasty DL; Wei SC; Hu MC; Walls MA; Bloom JJ; Dale JB
Infect Immun; 2001 May; 69(5):2943-9. PubMed ID: 11292710
[TBL] [Abstract][Full Text] [Related]
16. Resistance to phagocytosis by group A streptococci: failure of deposited complement opsonins to interact with cellular receptors.
Weis JJ; Law SK; Levine RP; Cleary PP
J Immunol; 1985 Jan; 134(1):500-5. PubMed ID: 3880574
[TBL] [Abstract][Full Text] [Related]
17. Domains of group A streptococcal M protein that confer resistance to phagocytosis, opsonization and protection: implications for vaccine development.
McArthur JD; Walker MJ
Mol Microbiol; 2006 Jan; 59(1):1-4. PubMed ID: 16359313
[TBL] [Abstract][Full Text] [Related]
18. Common protective antigens of group A streptococcal M proteins masked by fibrinogen.
Whitnack E; Dale JB; Beachey EH
J Exp Med; 1984 Apr; 159(4):1201-12. PubMed ID: 6368736
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of chicken embryos to group A streptococci: correlation with fibrinogen binding.
Schmidt KH; Wiesner J; Gerlach D; Reichardt W; Ozegowski JH; Köhler W
FEMS Immunol Med Microbiol; 1993 Oct; 7(3):231-40. PubMed ID: 8275054
[TBL] [Abstract][Full Text] [Related]
20. Effect of subinhibitory concentrations of josamycin on the expression of M protein by group A streptococci.
Lam C; Basalka E
Eur J Clin Microbiol; 1985 Jun; 4(3):279-81. PubMed ID: 3894016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
